Reduced Community-acquired Respiratory Virus Infection, but Not Non-virus Infection, in Lung Transplant Recipients During Government-mandated Public Health Measures to Reduce COVID-19 Transmission.

Compared with the MASK cohort, the POST cohort (161 d in cohort) demonstrated a rebound in CARV incidence rate (Figure 1 A; MASK, 14.3 versus POST, 33.6 positive tests per 100 000 test-days), but the difference in CARV cumulative incidence did not reach statistical significance (0.062 versus 0.054, MASK versus POST, respectively, P = 0.86).

also in 111,027 other papers